IONS
Ionis Pharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology · US
$58.09
−0.07%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- 316.59x
- P/S forward
- 10.34x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 21.95x
- Price / sales
- 11.05x
- Price / cash flow
- -19.45x
Enterprise value
- Enterprise value
- $10.0B
- EV / sales
- 11.46x
- EV / EBITDA
- 2.31x
- EV / EBIT
- -16.84x
- Market cap
- $9.7B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026